Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia.
Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia.
Int J Mol Sci. 2023 Jul 24;24(14):11844. doi: 10.3390/ijms241411844.
Ecdysone signaling in remains a popular model for investigating the mechanisms of steroid action in eukaryotes. The ecdysone receptor EcR can effectively bind ecdysone-response elements with or without the presence of a hormone. For years, EcR enhancers were thought to respond to ecdysone via recruiting coactivator complexes, which replace corepressors and stimulate transcription. However, the exact mechanism of transcription activation by ecdysone remains unclear. Here, we present experimental data on 11 various coregulators at ecdysone-responsive loci of S2 cells. We describe the regulatory elements where coregulators reside within these loci and assess changes in their binding levels following 20-hydroxyecdysone treatment. In the current study, we detected the presence of some coregulators at the TSSs (active and inactive) and boundaries marked with CP190 rather than enhancers of the ecdysone-responsive loci where EcR binds. We observed minor changes in the coregulators' binding level. Most were present at inducible loci before and after 20-hydroxyecdysone treatment. Our findings suggest that: (1) coregulators can activate a particular TSS operating from some distal region (which could be an enhancer, boundary regulatory region, or inactive TSS); (2) coregulators are not recruited after 20-hydroxyecdysone treatment to the responsive loci; rather, their functional activity changes (shown as an increase in H3K27 acetylation marks generated by CBP/p300/Nejire acetyltransferase). Taken together, our findings imply that the 20-hydroxyecdysone signal enhances the functional activity of coregulators rather than promoting their binding to regulatory regions during the ecdysone response.
蜕皮激素信号在 中仍然是一个流行的模型,用于研究真核生物中类固醇作用的机制。蜕皮激素受体 EcR 可以有效地结合蜕皮激素反应元件,无论是否存在激素。多年来,EcR 增强子被认为通过招募共激活复合物来响应蜕皮激素,这些复合物取代了核受体抑制物并刺激转录。然而,蜕皮激素激活转录的确切机制仍不清楚。在这里,我们在 S2 细胞的蜕皮激素反应基因座上展示了关于 11 种不同共调节剂的实验数据。我们描述了这些基因座中核心调节剂所在的调节元件,并评估了 20-羟基蜕皮激素处理后它们结合水平的变化。在当前的研究中,我们在 TSS(活性和非活性)和带有 CP190 标记的边界处检测到一些核心调节剂的存在,而不是 EcR 结合的蜕皮激素反应基因座的增强子。我们观察到核心调节剂结合水平的微小变化。大多数在 20-羟基蜕皮激素处理前后存在于可诱导基因座上。我们的研究结果表明:(1)核心调节剂可以激活来自某些远端区域(可能是增强子、边界调节区域或非活性 TSS)的特定 TSS;(2)核心调节剂不是在 20-羟基蜕皮激素处理后被招募到反应基因座;相反,它们的功能活性发生变化(表现为 CBP/p300/Nejire 乙酰转移酶产生的 H3K27 乙酰化标记增加)。总之,我们的研究结果表明,20-羟基蜕皮激素信号增强了核心调节剂的功能活性,而不是在蜕皮激素反应期间促进它们与调节区域的结合。